Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QG8F
|
|||
| Former ID |
DIB007766
|
|||
| Drug Name |
DNCB
|
|||
| Synonyms |
1-Chloro-2,4-dinitrobenzene
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Immune System disease [ICD-11: 4A01-4B41] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C6H3ClN2O4
|
|||
| Canonical SMILES |
C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl
|
|||
| InChI |
1S/C6H3ClN2O4/c7-5-2-1-4(8(10)11)3-6(5)9(12)13/h1-3H
|
|||
| InChIKey |
VYZAHLCBVHPDDF-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 97-00-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
1917, 72281, 598708, 3136115, 5254507, 7675940, 8150407, 10538855, 12075450, 15220052, 17395397, 22389130, 24848362, 24854237, 26757478, 36535158, 48413412, 48417000, 49856122, 50183835, 51073324, 53787752, 57260144, 57264331, 57319883, 58023885, 85084731, 85084732, 85172477, 85240164, 87565336, 88800368, 93166146, 103110650, 103249990, 104293572, 104667369, 117377587, 117558395, 118053788, 124800650, 124892793, 124892794, 125324001, 125360418, 126653061, 126678588, 128846853, 129547292, 131053624
|
|||
| ChEBI ID |
CHEBI:34718
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00000870) A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.